Press Release Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial 9 November 2025
Press Release Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease 9 November 2025
Press Release Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Life Insurance Segment 9 November 2025
Press Release Stepful Keeps Healthcare Training Free for Military Families Amid Government Shutdown 9 November 2025
Press Release Anumana Advances AI-Driven Cardiovascular Science with Late-Breaking Heart Failure Study and Multiple Abstracts at AHA 2025 9 November 2025
Press Release Teledyne FLIR Defense Names Riyadh-Based Managing Director for Middle East and North Africa 9 November 2025
Press Release Workers at Aimbridge-operated hotels in Los Angeles and Philadelphia strike during event-filled weekend, UNITE HERE reports 9 November 2025
Press Release Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week 8 November 2025
Press Release New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM 8 November 2025
Press Release United States Otorhinolaryngology KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs) – ResearchAndMarkets.com 8 November 2025
